{
    "2019-05-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy",
                "features": {
                    "keywords": [
                        "Goldman Sachs",
                        "Big Pharma",
                        "Stocks to Buy"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "British Columbia to be first Canadian province to switch patients to biosimilars",
                "features": {
                    "keywords": [
                        "British Columbia",
                        "Canadian",
                        "biosimilars"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly",
                        "report"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-20",
                "original_text": "Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Licensing Agreement",
                        "Non-Opioid Pain",
                        "Centrexion Therapeutics"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}